Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous methotrexate versus placebo in moderate to severe psoriasis vulgaris
NL-OMON39795Phase 3Active, not recruiting
- Sponsor
- Prof. Kristian Reich
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis comparing Methotrexate with Placebo to methotrexate crossover (2 arms). Started Feb 2013; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NL-OMON39795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39795.